Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis

Open access
Relph, Sophie, Patel, Trusha, Delaney, Louisa, Sobhy, Soha, Thangaratinam, Shakila · 2021 · PLOS Medicine

Abstract

BACKGROUND: The rise in the global prevalence of diabetes, particularly among younger people, has led to an increase in the number of pregnant women with preexisting diabetes, many of whom have diabetes-related microvascular complications. We aimed to estimate the magnitude of the risks of adverse pregnancy outcomes or disease progression in this population. METHODS AND FINDINGS: We undertook a systematic review and meta-analysis on maternal and perinatal complications in women with type 1 or 2 diabetic microvascular disease and the risk factors for worsening of microvascular disease in pregnancy using a prospective protocol (PROSPERO CRD42017076647). We searched major databases (January 1990 to July 2021) for relevant cohort studies. Study quality was assessed using the Newcastle-Ottawa Scale. We summarized the findings as odds ratios (ORs) with 95% confidence intervals (CIs) using random effects meta-analysis. We included 56 cohort studies involving 12,819 pregnant women with diabetes; including 40 from Europe and 9 from North America. Pregnant women with diabetic nephropathy were at greater risk of preeclampsia (OR 10.76, CI 6.43 to 17.99, p < 0.001), early (<34 weeks) (OR 6.90, 95% CI 3.38 to 14.06, p < 0.001) and any preterm birth (OR 4.48, CI 3.40 to 5.92, p < 0.001), and cesarean section (OR 3.04, CI 1.24 to 7.47, p = 0.015); their babies were at higher risk of perinatal death (OR 2.26, CI 1.07 to 4.75, p = 0.032), congenital abnormality (OR 2.71, CI 1.58 to 4.66, p < 0.001), small for gestational age (OR 16.89, CI 7.07 to 40.37, p < 0.001), and admission to neonatal unit (OR 2.59, CI 1.72 to 3.90, p < 0.001) compared to those without nephropathy. Diabetic retinopathy was associated with any preterm birth (OR 1.67, CI 1.27 to 2.20, p < 0.001) and preeclampsia (OR 2.20, CI 1.57 to 3.10, p < 0.001) but not other complications. The risks of onset or worsening of retinopathy were increased in women who were nulliparous (OR 1.75, 95% CI 1.28 to 2.40, p < 0.001), smokers (OR 2.31, 95% CI 1.25 to 4.27, p = 0.008), with existing proliferative disease (OR 2.12, 95% CI 1.11 to 4.04, p = 0.022), and longer duration of diabetes (weighted mean difference: 4.51 years, 95% CI 2.26 to 6.76, p < 0.001) compared to those without the risk factors. The main limitations of this analysis are the heterogeneity of definition of retinopathy and nephropathy and the inclusion of women both with type 1 and type 2 diabetes. CONCLUSIONS: In pregnant women with diabetes, presence of nephropathy and/or retinopathy appear to further increase the risks of maternal complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003856

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA flow chart of included studies in the systematic review.
Fig 1 PRISMA flow chart of included studies in the systematic review.CC BY · PubMed Central
Fig 2 Quality of the studies included in the systematic review for study selection, comparability, and ascertainment of outcome.
Fig 2 Quality of the studies included in the systematic review for study selection, comparability, and ascertainment of outcome.CC BY · PubMed Central
Fig 3 Association between diabetic nephropathy and adverse maternal and perinatal outcomes.
Fig 3 Association between diabetic nephropathy and adverse maternal and perinatal outcomes.CC BY · PubMed Central
Fig 4 Association between diabetic retinopathy and adverse maternal and perinatal outcomes.
Fig 4 Association between diabetic retinopathy and adverse maternal and perinatal outcomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Research works printed but not linked: 5

  1. T Patel, 2017, Maternal and offspring outcomes in pregnant women with pre-existing diabetes complicated by nephropathy and retinopathy: a systematic review and meta-analysis
  2. L Ringholm, 2011, Higher levels of Atrial Natriuretic Peptide (ANP) are present in early pregnancy in type 1 diabetic women developing preeclampsia, September 2011, 54, S485
  3. A Dodesini, 2009, In type 1 diabetic women retinopathy and nephropathy are predictors of caesarean delivery independently of glucose control, Diabetes, 58
  4. H Hopp, 1995, Diabetic retinopathy and nephropathy—Complications during pregnancy and delivery, Geburtshilfe Frauenheilkd, 55, 275
  5. M Lovestam-Adrian, 1997, Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients, Diabet Med, 14, 1059, 10.1002/(SICI)1096-9136(199712)14:12<1059::AID-DIA505>3.0.CO;2-8 · doi:10.1002/(sici)1096-9136(199712)14:12<1059::aid-dia505>3.0.co;2-8

Cited by

See all 54

Metadata

Authors
Relph, S., Patel, T., Delaney, L., Sobhy, S., & Thangaratinam, S.
Affiliations
  • King's College London (GB)
  • Royal Free London NHS Foundation Trust (GB)
  • Queen Mary University of London (GB)
  • Birmingham Women’s and Children’s NHS Foundation Trust (GB)
Corresponding author
Thangaratinam, Shakila
Venue
PLOS Medicine
Published
2021-11-22
Volume
18
Issue
11
Pages
e1003856
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W3216427723
Cited by
54
References
78
Citations by year
2026: 7 · 2025: 12 · 2024: 14 · 2023: 12 · 2022: 8 · 2021: 1
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute for Health and Care Research (NIHR202435, CL-2016-19-002)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
diabetes in pregnancy, diabetic microangiopathy, diabetic nephropathy, preeclampsia, preterm birth, cesarean section, perinatal mortality, congenital malformations, small for gestational age, neonatal admission, disease progression, type 1 diabetes, type 2 diabetes, maternal complications, perinatal complications, risk factors
MeSH terms
Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Risk Factors, Publication Bias, Disease Progression, Microvessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pmed.1003856
The paper
Relph, S., Patel, T., Delaney, L., Sobhy, S., & Thangaratinam, S. (2021). Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003856

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.